Literature DB >> 2259400

Surgical decompression without transposition for ulnar neuropathy: factors determining outcome.

P D LeRoux1, T D Ensign, K J Burchiel.   

Abstract

Fifty-one surgical decompressions without nerve transposition for ulnar neuropathy were performed in 46 patients. All of the patients were men with an average age of 59 years at the time of surgery. The follow-up range was between 5 and 32 months (average, 17.8 months). The disease involved the nondominant arm in 24 patients (52%) and was bilateral in 5 (11%). In 23 cases (50%), no predisposing condition could be identified, whereas 15 patients (33%) abused alcohol and 8 patients (17%) had diabetes mellitus. Fifty-seven percent of the patients helped by surgery had symptoms for less than 1 year, whereas only 30% of patients with symptoms for more than 1 year had symptomatic improvement. The relative magnitude of the slowing of ulnar nerve conduction velocity across the elbow was not significantly correlated with the success of decompression in relieving symptoms. Ulnar nerve conduction velocities across the elbow were 36.13 +/- 11.76 m/s in those responding to surgery and 38.97 +/- 13.91 m/s in those not responding (c = 0.06, dF = 50, P less than 0.3). A total of 37 patients showed symptomatic improvement after decompression. Simple decompression of the ulnar nerve was performed under local anesthesia without transposition of the nerve. In all of these cases, compression of the nerve occurred predominantly in the epicondylar groove. Narrowing of the nerve in the groove was present in 28 cases (55%); scar tissue was found adhering to the nerve in 21 cases (41%); and two pseudoneuromas were found (4%). Forty-one operations (80%) resulted in symptomatic improvement, typically noted by the patient within the first month postoperatively.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1990        PMID: 2259400     DOI: 10.1097/00006123-199011000-00007

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  8 in total

1.  Entrapment neuropathy at the cubital tunnel: simple decompression is the method of choice.

Authors:  H H Steiner; M S von Haken; H G Steiner-Milz
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

Review 2.  Complications of compressive neuropathy: prevention and management strategies.

Authors:  Katherine B Santosa; Kevin C Chung; Jennifer F Waljee
Journal:  Hand Clin       Date:  2015-03-02       Impact factor: 1.907

3.  Cubital Tunnel Decompression: Equivalent Outcome Scores when Procedure Performed with Local versus General Anesthetic.

Authors:  S H Ajwani; R M Unsworth; M Tseng; M Madi; A Berg; J G Warner; P R Wykes
Journal:  J Hand Microsurg       Date:  2018-12-14

4.  Predictors of functional outcomes after simple decompression for ulnar neuropathy at the elbow: a multicenter study by the SUN study group.

Authors:  Patricia B Burns; H Myra Kim; R Glenn Gaston; Steven C Haase; Warren C Hammert; Jeffrey N Lawton; Greg A Merrell; Paul F Nassab; Lynda J Yang; Kevin C Chung
Journal:  Arch Phys Med Rehabil       Date:  2013-11-16       Impact factor: 3.966

5.  Cubital tunnel release with two limited incisions: a cadaver study.

Authors:  M Alp; S M Akkin; L Yalçin; T Marur; M Babacan
Journal:  Surg Radiol Anat       Date:  2004-06-10       Impact factor: 1.246

6.  Use of ultrasonography in ulnar nerve entrapment surgery--a prospective study.

Authors:  Murat Kutlay; Ahmet Colak; Hakan Simşek; Ersin Oztürk; Mehmet Güney Senol; Kivanç Topuz; Mehmet Nusret Demircan
Journal:  Neurosurg Rev       Date:  2008-09-17       Impact factor: 3.042

7.  Patient-reported outcome of surgical treatment of nerve entrapments in the proximal forearm.

Authors:  Birgitta Svernlöv; Göran Nylander; Lars Adolfsson
Journal:  Adv Orthop       Date:  2011-09-11

8.  Effects of tendon transfer to restore index finger abduction for severe cubital tunnel syndrome.

Authors:  Shingo Nobuta; Katsumi Sato; Kenji Kanazawa; Masahito Hatori; Eiji Itoi
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.